209 related articles for article (PubMed ID: 31757308)
1. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
[TBL] [Abstract][Full Text] [Related]
3. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
4. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine.
Khatri VP; Petrelli NJ
Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
[No Abstract] [Full Text] [Related]
6. Precision Medicine in the Treatment of Melanoma.
Aderhold K; Wilson M; Berger AC; Levi S; Bennett J
Surg Oncol Clin N Am; 2020 Jan; 29(1):1-13. PubMed ID: 31757306
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
8. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
9. Individualizing Care: Management Beyond Medical Therapy.
Cristoferi L; Nardi A; Invernizzi P; Mells G; Carbone M
Surg Oncol Clin N Am; 2020 Jan; 29(1):87-103. PubMed ID: 31757316
[TBL] [Abstract][Full Text] [Related]
10. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine in Lung Cancer Treatment.
Shah DR; Masters GA
Surg Oncol Clin N Am; 2020 Jan; 29(1):15-21. PubMed ID: 31757310
[TBL] [Abstract][Full Text] [Related]
12. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.
Ennishi D; Hsi ED; Steidl C; Scott DW
Cancer Discov; 2020 Sep; 10(9):1267-1281. PubMed ID: 32616477
[TBL] [Abstract][Full Text] [Related]
13. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
Corey L; Valente A; Wade K
Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
[TBL] [Abstract][Full Text] [Related]
14. Precision Medicine for Diffuse Large B-cell Lymphoma.
Lim MS; Elenitoba-Johnson KS
Clin Cancer Res; 2016 Jun; 22(12):2829-31. PubMed ID: 26988247
[TBL] [Abstract][Full Text] [Related]
15. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
Wright GW; Huang DW; Phelan JD; Coulibaly ZA; Roulland S; Young RM; Wang JQ; Schmitz R; Morin RD; Tang J; Jiang A; Bagaev A; Plotnikova O; Kotlov N; Johnson CA; Wilson WH; Scott DW; Staudt LM
Cancer Cell; 2020 Apr; 37(4):551-568.e14. PubMed ID: 32289277
[TBL] [Abstract][Full Text] [Related]
16. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
Iqbal J; Shen Y; Huang X; Liu Y; Wake L; Liu C; Deffenbacher K; Lachel CM; Wang C; Rohr J; Guo S; Smith LM; Wright G; Bhagavathi S; Dybkaer K; Fu K; Greiner TC; Vose JM; Jaffe E; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Armitage JO; Weisenburger DD; Staudt LM; Gascoyne RD; McKeithan TW; Chan WC
Blood; 2015 Feb; 125(7):1137-45. PubMed ID: 25498913
[TBL] [Abstract][Full Text] [Related]
17. Emerging prognostic factors in diffuse large B cell lymphoma.
Gascoyne RD
Curr Opin Oncol; 2004 Sep; 16(5):436-41. PubMed ID: 15314511
[TBL] [Abstract][Full Text] [Related]
18. Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice.
Weber T; Schmitz R
Curr Oncol Rep; 2022 Jan; 24(1):13-21. PubMed ID: 35060000
[TBL] [Abstract][Full Text] [Related]
19. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.
de Jong D; Balagué Ponz O
J Pathol; 2011 Jan; 223(2):274-82. PubMed ID: 21125680
[TBL] [Abstract][Full Text] [Related]
20. New developments in extracutaneous lymphomas.
Chott A; Raderer M
Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]